Jiménez-Méndez E, Fuentes-Yunes C, Méndez-Hernández CL, Aldape-Barrios BC

Language: Spanish
References: 14
Page: 225-229
PDF size: 242.59 Kb.

ABSTRACT

Squamous cell carcinoma, also known as epidermoid or squamous cell carcinoma, is the most common malignant neoplasm in the oral cavity and oropharynx. It represents 3 to 5% of all neoplasms and metastasizes to regional lymph nodes. There are multiple risk factors, with excessive alcohol and tobacco consumption being the most recognized. Parafunctional movements, hygiene and nutrition, and of course genetics, are all important factors in the development of this carcinoma. It has a higher prevalence in males, although in recent years there has been an increase in females, possibly due to increased alcohol and tobacco consumption. The age range typically affected is the 4th to 6th decade of life, due to the increased alcohol and tobacco consumption within this age range. The most common locations are the lateral border of the tongue and the floor of the mouth. The clinical presentation varies and can initially appear as an asymptomatic white or red plaque, exophytic, ulcerated, granular, or with indurated borders. The treatment should involve radical surgery with radiotherapy or chemotherapy, and the prognosis depends on the timing of diagnosis.

REFERENCES

1. Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010; 46 (6): 414-417. doi: 10.1016/j.oraloncology.2010.03.009.

2. Barnes L, Eveson J, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. 3rd ed. Geneva: World Health Organization; 2022. p. 165-177.

3. Prada VOE, Trinidad JI, Granados GM. Incidencia y experiencia en el manejo del cáncer de cavidad oral en el Instituto Nacional de Cancerología de México. Rev Mex Cir Bucal Maxilofac. 2021; 17 (3): 111-121. doi: 10.35366/105390.

4. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002; 52 (1): 23-47. doi: 10.3322/canjclin.52.1.23.

5. Barboza I, Camacho A, Gutiérrez G, Tacsan L. Epidemiología del cáncer bucal en Costa Rica en el período de 1981-1994. Seminario de graduación [Tesis]. Costa Rica: Facultad de Odontología, Universidad de Costa Rica; 1997.

6. Anaya-Saavedra G, Ramírez-Amador V, Irigoyen-Camacho ME, Zimbrón-Romero A, Zepeda-Zepeda MA. Oral and pharyngeal cancer mortality rates in Mexico, 1979-2003: Oral and pharyngeal cancer mortality in Mexico. J Oral Pathol Med. 2008; 37: 11-17. doi: 10.1111/j.1600-0714.2007.00562.x.

7. American Cancer Society. Estadísticas importantes sobre los tipos de cáncer de orofaringe y de cavidad oral. American Cancer Society. 2023 [consultado el 5 de mayo de 2023]. Disponible en: https://www.cancer.org/es/cancer/tipos/cancer-de-orofaringe-y-de-cavidad-oral/acerca/estadisticas-clave.html

8. Epstein JB, Scully C. Assessing the patient at risk for oral squamous cell carcinoma. Spec Care Dentist. 1997; 17: 120-128. doi: 10.1111/j.1754-4505.1997.tb00881.x.

9. Rizo P, Sierra MI, Vázquez G, Galicia-Vázquez G. Registro hospitalario de cáncer: compendio de cáncer 2000-2004. Cancerología. 2007; 2: 203-287.

10. Salgado RB, Rivera M, Altamirano Díaz. Frecuencia de carcinoma de cavidad oral en un Hospital de tercer nivel. Rev Sanid Milit Mex. 2014; 68 (3): 172-176.

11. Meneses GA, Mosqueda TA, Ruiz-Godoy RL. Lesiones tumorales y seudotumorales. En: Patología quirúrgica de cabeza y cuello. México: Trillas; 2006. p. 45-79.

12. Cuffari L, Tesseroli de Siqueira JT, Nemr K, Rapaport A. Pain complaint as the first symptom of oral cancer: a descriptive study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102 (1): 56-61. doi: 10.1016/j.tripleo.2005.10.041.

13. British Columbia Oral Cancer Prevention Program, BC Cancer Agency; College of Dental Surgeons of British Columbia. Guideline for the early detection of oral cancer in British Columbia 2008. J Can Dent Assoc. 2008; 74 (3): 245.

14. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005; 365 (9475): 1927-1933.